Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Eligibility criteria
Qualifiers
Patients undergoing elective upper endoscopy with gastroenterology team
Disqualifiers
Urgent or emergent procedure
Inclusion of colonoscopy or antegrade small bowel enteroscopy in planned procedure
Upper GI barium study performed in past 24 hours.
Gastroparesis
Trial design
Treatments tested in this trial
- Modified Fasting Guidelines
Treatment groups
150 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov